2016至2018年比利时PCV13至PCV10疫苗接种规划转换期间及之后鼻咽部肺炎球菌携带演变
该观察性研究在2016至2018年三个时期采集了2,615份日托儿童(6-30月龄)鼻咽拭子,监测肺炎链球菌(Sp)血清型及流感嗜血杆菌(Hi)携带情况。Sp携带率(>75%)保持稳定,Hi携带率上升(2016年87.4%,664/760 vs 2017-2018年93.9%,895/953)。非PCV13疫苗血清型比例下降(94.6%,438/463 vs 89.7%,599/668),而PCV13非PCV10血清型(3+6A+19A)比例上升(0.9%,4/463 vs 7.8%,52/668),以19A最常见(87.9%,58/66)。
要点
- Sp携带率(>75%)在三个时期保持稳定。
- Hi携带率从2016年87.4%(664/760)升至2017-2018年93.9%(895/953)。
- PCV13非PCV10血清型比例从2016年0.9%(4/463)升至2017-2018年7.8%(52/668)。
核心结论
- 在PCV13至PCV10疫苗转换期间及之后,非PCV13血清型比例下降,主要因19A血清型携带率上升。
- 这些结果补充了侵袭性肺炎球菌病监测数据,为肺炎球菌疫苗接种规划政策制定提供进一步依据。
研究设计与样本
- 观察性研究,监测2016至2018年三个时期比利时日托儿童(6-30月龄)鼻咽部肺炎链球菌和流感嗜血杆菌携带情况。
- 共采集2,615份鼻咽拭子,通过问卷获取人口学、临床特征和疫苗接种状态。
- 用培养和PCR鉴定Sp和Hi,用纸片扩散法检测抗菌药物敏感性,用Quellung反应及PCR进行血清分型(针对血清型3、6A、19A)。
主要发现
- Sp携带率(>75%)在连续时期保持稳定。
- Hi携带率从2016年87.4%(664/760)上升至2017-2018年93.9%(895/953)。
- 非PCV13疫苗血清型比例从2016年94.6%(438/463)下降至2017-2018年89.7%(599/668)。
- PCV13非PCV10疫苗血清型(3+6A+19A)比例从2016年0.9%(4/463)上升至2017-2018年7.8%(52/668)。
- 血清型19A最常被识别(87.9%,58/66株);对任一测试抗生素的非敏感性在研究期间稳定(>44%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundThe current carriage study was set up to reinforce surveillance during/after the PCV13-to-PCVC10 switch in Belgium.AimThis observational study monitored carriage of Streptococcus pneumoniae (Sp) serotypes, particularly those no longer covered (3, 6A, 19A), as well as Haemophilus influenzae (Hi), because PCV10 contains the non-typeable Hi protein D.MethodsA total of 2,615 nasopharyngeal swabs from children (6-30 months old) attending day care were collected in three periods over 2016-2018. Children's demographic and clinical characteristics and vaccination status were obtained through a questionnaire. Sp and Hi were identified by culture and PCR. Pneumococcal strains were tested for antimicrobial (non-)susceptibility by disc diffusion and serotyped by Quellung-reaction (Quellung-reaction and PCR for serotypes 3, 6A, 19A).ResultsThe carriage prevalence of Sp (> 75%) remained stable over the successive periods but that of Hi increased (87.4%, 664 Hi-carriers/760 in 2016 vs 93.9%, 895/953 in 2017-2018). The proportion of non-PCV13 vaccine serotypes decreased (94.6%, 438 isolates/463 in 2016 vs 89.7%, 599/668 in 2017-2018) while that of PCV13-non-PCV10 vaccine serotypes (3 + 6A + 19A) increased (0.9%, 4 isolates/463 in 2016 vs 7.8%, 52/668 in 2017-2018), with serotype 19A most frequently identified (87.9%, 58/66 isolates). Non-susceptibility of pneumococci against any of the tested antibiotics was stable over the study period (> 44%).ConclusionsDuring and after the PCV13-to-PCV10 vaccine switch, the proportion of non-PCV13 serotypes decreased, mainly due to a serotype 19A carriage prevalence increase. These results complement invasive pneumococcal disease surveillance data, providing further basis for pneumococcal vaccination programme policy making.
引用
- Wouters I, Desmet S, Van Heirstraeten L, et al. How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018. Euro Surveill. 2020. PMID: 32046817. doi:10.2807/1560-7917.ES.2020.25.5.1900303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。